Announce Date | 08/06/2025 |
EPS Normalized Actual | $-0.01 (Beat by $0.11) |
EPS GAAP Actual | $-0.01 (Beat by $0.11) |
Revenue Actual | $1.394B |
Revenue Surprise | Beat by $1394M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Sep 2029 | 3.22 | 10.13 | 3.1793 | 3.26103 | 1 |
Sep 2028 | 2.96 | 11.02 | 2.88231 | 3.03769 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | -0.76 | -0.76 | 1.394B | 1% | 1394M |
FQ1 2025 (Mar 2025) | 2.23 | 2.23 | 2.666B | 7.46% | 2666M |
FQ4 2024 (Dec 2024) | 1.74 | 1.74 | 2.03B | -4.48% | 2030M |
FQ3 2024 (Sep 2024) | 0 | 0 | 1.242B | -13.04% | 1242M |
FQ2 2024 (Jun 2024) | -0.23 | -0.23 | 1.38B | -20.22% | 1380M |
FQ1 2024 (Mar 2024) | 2.3 | 2.3 | 2.467B | -25.9% | 2467M |
FQ4 2023 (Dec 2023) | 0.0004 | 0.0004 | 2.121B | -30.08% | 2121M |
FQ3 2023 (Sep 2023) | 0.62 | 0.62 | 1.404B | 100% | 1404M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ2 2029 (Jun 2029) | 0.0807 | -- | 0.0807 | 0.0807 | 1 |
FQ1 2029 (Mar 2029) | 2.9597 | -- | 2.9597 | 2.9597 | 1 |
FQ4 2028 (Dec 2028) | 1.2301 | -- | 1.2301 | 1.2301 | 1 |
FQ2 2028 (Jun 2028) | 0.056879 | -- | 0.056879 | 0.056879 | 1 |
FQ1 2028 (Mar 2028) | 2.75568 | -- | 2.75568 | 2.75568 | 1 |
FQ4 2027 (Dec 2027) | 1.23222 | -- | 1.23222 | 1.23222 | 1 |
FQ2 2027 (Jun 2027) | 0.1745 | -- | 0.1745 | 0.1745 | 1 |
FQ1 2027 (Mar 2027) | 2.5535 | -- | 2.5535 | 2.5535 | 1 |
FQ4 2026 (Dec 2026) | 0.8044 | -- | 0.8044 | 0.8044 | 1 |
FQ2 2026 (Jun 2026) | 0.1221 | 722.44 | 0.1221 | 0.1221 | 1 |
FQ1 2026 (Mar 2026) | 2.12 | -5.19 | 2.12 | 2.12 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ2 2029 (Jun 2029) | 2.48B | -- | 2.48B | 2.48B | 1 |
FQ1 2029 (Mar 2029) | 2.46B | -- | 2.46B | 2.46B | 1 |
FQ4 2028 (Dec 2028) | 1.63B | -- | 1.63B | 1.63B | 1 |
FQ2 2028 (Jun 2028) | 2.37B | -- | 2.37B | 2.37B | 1 |
FQ1 2028 (Mar 2028) | 2.35B | -- | 2.35B | 2.35B | 1 |
FQ4 2027 (Dec 2027) | 1.56B | -- | 1.56B | 1.56B | 1 |
FQ2 2027 (Jun 2027) | 1.68B | -- | 1.68B | 1.68B | 1 |
FQ1 2027 (Mar 2027) | 1.65B | -- | 1.65B | 1.65B | 1 |
FQ4 2026 (Dec 2026) | 1.63B | -- | 1.63B | 1.63B | 1 |
FQ2 2026 (Jun 2026) | 1.57B | 11.44 | 1.57B | 1.57B | 1 |
FQ1 2026 (Mar 2026) | 1.55B | -72.19 | 1.55B | 1.55B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
2
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | -0.76 | -0.76 | 100% | |
FQ1 2025 (Mar 2025) | 2.23 | 2.23 | 100% | |
FQ4 2024 (Dec 2024) | 1.74 | 1.74 | 100% | |
FQ3 2024 (Sep 2024) | 0 | 0 | NAN% | |
FQ2 2024 (Jun 2024) | -0.23 | -0.23 | 100% | |
FQ1 2024 (Mar 2024) | 2.3 | 2.3 | 100% | |
FQ4 2023 (Dec 2023) | 0.0004 | 0.0004 | 100% | |
FQ3 2023 (Sep 2023) | 0.62 | 0.62 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $0B | $1.39B | $1394M | 100% |
FQ1 2025 (Mar 2025) | $0B | $2.67B | $2666M | 100% |
FQ4 2024 (Dec 2024) | $0B | $2.03B | $2030M | 100% |
FQ3 2024 (Sep 2024) | $0B | $1.24B | $1242M | 100% |
FQ2 2024 (Jun 2024) | $0B | $1.38B | $1380M | 100% |
FQ1 2024 (Mar 2024) | $0B | $2.47B | $2467M | 100% |
FQ4 2023 (Dec 2023) | $0B | $2.12B | $2121M | 100% |
FQ3 2023 (Sep 2023) | $0B | $1.4B | $1404M | 100% |